Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Garlind

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Molecular and Cellular Biochemistry|August 1, 1995
Disturbances in signal transduction mechanisms in Alzheimer's diseaseC J Fowler, R F Cowburn, A Garlind, et al.
Journal of Neural Transmission. General Section|January 1, 1992
Neurotransmitter-mediated inhibition of post-mortem human brain adenylyl cyclaseA Garlind, C J Fowler, I Alafuzoff, et al.
Neuroscience Letters|February 9, 1995
Preservation of kappa 1 opioid receptor recognition site density and regulation by G-proteins in the temporal cortex of patients with Alzheimer's diseaseA Garlind, R F Cowburn, B Wiehager, et al.
Neurochemistry International|May 28, 2010
Characterization and regional distribution of adenylyl cyclase activity from human brainR F Cowburn, A Garlind, C O'Neill, et al.
Brain Research|May 29, 1995
Diminished [3H]inositol(1,4,5)P3 but not [3H]inositol(1,3,4,5)P4 binding in Alzheimer's disease brainA Garlind, R F Cowburn, C Forsell, et al.
Journal of the Neurological Sciences|October 1, 1991
Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brainL Bergström, A Garlind, L Nilsson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1991
Somatostatin receptors and the modulation of adenylyl cyclase activity in Alzheimer's diseaseR F Cowburn, C J Fowler, A Garlind, et al.
European Journal of Pharmacology|January 23, 1990
Effect of monovalent ions upon G proteins coupling muscarinic receptors to phosphoinositide hydrolysis in the rat cerebral cortexG Tiger, P E Björklund, R F Cowburn, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|June 1, 1996
Decreased inositol (1,4,5)-trisphosphate receptor levels in Alzheimer's disease cerebral cortex: selectivity of changes and possible correlation to pathological severityL S Haug, A C Ostvold, R F Cowburn, et al.
Neurochemical Research|August 10, 2001
The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defenseE Karelson, N Bogdanovic, A Garlind, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Molecular and Cellular Biochemistry|August 1, 1995
Disturbances in signal transduction mechanisms in Alzheimer's diseaseC J Fowler, R F Cowburn, A Garlind, et al.
Journal of Neural Transmission. General Section|January 1, 1992
Neurotransmitter-mediated inhibition of post-mortem human brain adenylyl cyclaseA Garlind, C J Fowler, I Alafuzoff, et al.
Neuroscience Letters|February 9, 1995
Preservation of kappa 1 opioid receptor recognition site density and regulation by G-proteins in the temporal cortex of patients with Alzheimer's diseaseA Garlind, R F Cowburn, B Wiehager, et al.
Neurochemistry International|May 28, 2010
Characterization and regional distribution of adenylyl cyclase activity from human brainR F Cowburn, A Garlind, C O'Neill, et al.
Brain Research|May 29, 1995
Diminished [3H]inositol(1,4,5)P3 but not [3H]inositol(1,3,4,5)P4 binding in Alzheimer's disease brainA Garlind, R F Cowburn, C Forsell, et al.
Journal of the Neurological Sciences|October 1, 1991
Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brainL Bergström, A Garlind, L Nilsson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 1, 1991
Somatostatin receptors and the modulation of adenylyl cyclase activity in Alzheimer's diseaseR F Cowburn, C J Fowler, A Garlind, et al.
European Journal of Pharmacology|January 23, 1990
Effect of monovalent ions upon G proteins coupling muscarinic receptors to phosphoinositide hydrolysis in the rat cerebral cortexG Tiger, P E Björklund, R F Cowburn, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration|June 1, 1996
Decreased inositol (1,4,5)-trisphosphate receptor levels in Alzheimer's disease cerebral cortex: selectivity of changes and possible correlation to pathological severityL S Haug, A C Ostvold, R F Cowburn, et al.
Neurochemical Research|August 10, 2001
The cerebrocortical areas in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defenseE Karelson, N Bogdanovic, A Garlind, et al.
Pageof 3